Anti-tumour necrosis factor treatment in a patient with anorexia nervosa and juvenile idiopathic arthritis

被引:15
|
作者
Barber, J [1 ]
Sheeran, T [1 ]
Mulherin, D [1 ]
机构
[1] Cannock Chase Hosp, Dept Rheumatol, Cannock WS11 2XY, England
关键词
D O I
10.1136/ard.62.5.490
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:490 / 491
页数:2
相关论文
共 50 条
  • [1] Anti-tumour necrosis factor-alpha treatment of juvenile idiopathic arthritis in a patient with common variable immunodeficiency
    Kilic, SS
    [J]. JOURNAL OF TROPICAL PEDIATRICS, 2005, 51 (03) : 194 - 195
  • [2] Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis
    C Rivarola
    C Hovhannessian
    A Duquesne
    R Cimaz
    [J]. Pediatric Rheumatology, 6 (Suppl 1)
  • [3] Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis
    Tynjala, P.
    Vahasalo, P.
    Honkanen, V.
    Lahdenne, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (04) : 552 - 557
  • [4] ANTI-TUMOUR NECROSIS FACTOR (ATNF) WEANING STRATEGY IN JUVENILE IDIOPATHIC ARTHRITIS (JIA): DOES LONGER DURATION MATTER?
    Arkachaisri, T.
    Teh, K. L.
    Book, Y. X.
    Gao, X.
    Das., L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 424 - 425
  • [5] AN EXPLORATION OF RHEUMATOID ARTHRITIS PATIENT'S EXPERIENCE OF ANTI-TUMOUR NECROSIS FACTOR (ANTI-TNF) TREATMENT
    Edwards, J.
    [J]. RHEUMATOLOGY, 2003, 42 : 152 - 152
  • [6] An exploration of rheumatoid arthritis patient's experience of anti-tumour necrosis factor (anti-TNF) treatment
    Edwards, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 557 - 558
  • [7] Primary nasal tuberculosis during anti-tumour necrosis factor alpha treatment of a patient with rheumatoid arthritis
    Ribeiro, Sofia
    Ferreira, Betania
    Duarte, Raquel
    Almeida, Isabel
    Vasconcelos, Carlos
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 45 (12) : 957 - 960
  • [8] Salmonella enterica Arthritis in a Patient with Rheumatoid Arthritis Receiving Anti-tumour Necrosis Factor Therapy
    Bubonja-Sonje, M.
    Rubinic, D.
    Anic, F.
    Novak, S.
    Vuckovic, D.
    Abram, M.
    [J]. WEST INDIAN MEDICAL JOURNAL, 2013, 62 (03): : 270 - 272
  • [9] Retention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis
    Hishitani, Y.
    Ogata, A.
    Shima, Y.
    Hirano, T.
    Ebina, K.
    Kunugiza, Y.
    Shi, K.
    Narazaki, M.
    Hagihara, K.
    Tomita, T.
    Yoshikawa, H.
    Tanaka, T.
    Kumanogoh, A.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (04) : 253 - 259
  • [10] ANTI-TUMOUR NECROSIS FACTOR (TNF) DRUGS FOR THE TREATMENT OF PSORIATIC ARTHRITIS (PSA)
    Farrell, J.
    Mills, E.
    Sheppard, O.
    Thorlund, K.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A440 - A440